Polypharmacy with common diseases in hospitalized elderly patients

American Journal Geriatric Pharmacotherapy

Volumn 10, Issue 2, 2012, Pages 123-128

  Mizokami, Fumihiro ^a   Koide, Yumiko ^a   Noro, Takeshi ^a   Furuta, Katsunori ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

common diseases; elderly; polypharmacy

Indexed keywords

PRESCRIPTION DRUG;

AGED; AGED HOSPITAL PATIENT; ANGINA PECTORIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; FEMALE; GERIATRIC DISORDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OSTEOPOROSIS; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH ULCER; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES;

EID: 84859529323     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2012.02.003     Document Type: Article

References (20)

1. van den Akker M, Buntinx F, Metsemakers JF, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367-375. (Pubitemid 28223302)
2. Gijsen R, Hoeymans N, Schellevis FG, et al. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661-674. (Pubitemid 32594852)
3. Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q. 1989;67:450-484. (Pubitemid 20232414)
4. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269-2276. (Pubitemid 35332510)
5. Boyd CM, Ritchie CS, Tipton EF, et al. From bedside to bench: summary from the American Geriatrics Society/ National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults. Aging Clin Exp Res. 2008;20:181-188.
6. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870-2874.
7. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716-724. (Pubitemid 41159291)
8. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch InternMed. 2004;164:1957-1959. (Pubitemid 39390550)
9. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345-351.
10. Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44:957-963.
11. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173-184. (Pubitemid 47049724)
12. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy: a longitudinal study. Fam Pract. 2000;17:261-267.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
14. Ferner RE, Aronson JK. Communicating information about drug safety. BMJ. 2006;333:143-145. (Pubitemid 44406787)
15. Wawruch M, Zikavska M, Wsolova L, et al. Polypharmacy in elderly hospitalised patients in Slovakia. Pharm World Sci. 2008;30:235-242. (Pubitemid 351550902)
16. Corsonello A, Pedone C, Corica F, Incalzi RA. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manage. 2007;3:197-203. (Pubitemid 46671835)
17. Schuler J, Duckelmann C, Beindl W, et al. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr. 2008;120:733-741.
18. Procyshyn RM, Honer WG, Wu TK, et al. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. J Clin Psychiatry. 2010;71:566-573.
19. Antonelli Incalzi R, Corsonello A, Pedone C, et al. Depression and drug utilization in an elderly population. Ther Clin Risk Manage. 2005;1:55-60.
20. Nobili A, Licata G, Salerno F, et al. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards: the REPOSI study. Eur J Clin Pharmacol. 2011;67:507-519.